Clinical Trial Update: Safety and Immunogenicity of a Trivalent Group B Streptococcus Vaccine in Healthy Pregnant Women [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on the safety and immunogenicity of a trivalent Group B Streptococcus vaccine in healthy pregnant women.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Group Streptococcus Infection in Newborns

Drugs mentioned

• GBS vaccine (trivalent Group B Streptococcus vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: GBS Disease, Streptococcus Agalactiae | Phase 2 | Status: COMPLETED | Results posted: 2017-05-30